中文
English
About Us
Company
Team
Honor
Vision & Mission
Contact Us
Pipeline
Innovation
Biosimilar
KN015
Long acting FSH used in infertility. IND in 2014
KN026
KN026: bispecific Ab against ERBB family, which showed improved tumor inhibiti...
R & D
Antibody Screening
Pharmacodynamics
Protein/Ab Engineering
Process Dev
Multi-functional Fc platform
While the specificity of mAbs are fully appreciated, at the early days, scien...
In vitro/In vivo Pharmaco...
In vitro/In vivo Pharmacology Evaluation Platform in Alphamab including cell b...
Manufacturing
DS/DP Production
Quality System
Partnering
Opportunities
Corporation
Academic
News
Press Release
Worth to be Noted
KN015 patent application ...
KN015 is a long acting FSH that designed via protein engineering by Alphamab. ...
Science's Breakthrough of the Year ...
Science's Breakthrough of the Year is the European Space Agency's Rosetta miss...
Career
Career opportunity
Apply On-line
News
Press Release
Worth to be Noted
---- Useful Link ----
Alphamab Jilin
DingFu Biotarget
Shihuida Pharma
CFDA
CDE
NIFDC
Press Release
Home
>
News
>
Press Release
>
Text
KN019项目成品灌装
Time：
2014-09-11
Source：admin
Print
Font size：
Big
Middle
Small
Close
Share：
Pre：
KN015 patent filed in China
Next：
徐霆博士在China Bio上接受Bioworld的采访
Home
|
About Us
|
Pipeline
|
R & D
|
Manufacturing
|
Partnering
|
News
|
Career
